Improving Type II Diabetes Care in West Africa: A Scoping Review of Barriers, Facilitators and the Way Forward - Abdul-Samed, Abdul-Basit; Jahan, Yasmin; Reichenberger, Veronika; Peprah, Ellen Barnie; Agyekum, Mary Pomaa; Lawson, Henry; Balabanova, Dina; Mirzoev, Tolib; Agyepong, Irene (medRxiv, 2024)
Background The prevalence of diabetes is rising rapidly across West Africa, posing a significant public health challenge. Effective diabetes management through accessible and quality primary healthcare is crucial, yet multiple barriers persist. This review aimed to synthesise the available evidence on factors influencing access, utilisation, and quality of diabetes primary care in West Africa.Methods Our scoping review followed Arksey and O’Malley’s methodology and PRISMA-ScR guidelines. We comprehensively searched electronic databases and grey literature for studies covering 2000-2023 that reported factors related to diabetes primary care in West African countries. Data was extracted and analysed through a framework synthesis approach integrating the World Health Organisation Operational Framework for Primary Health Care, the Social Determinants of Health model, and the Innovative Care for Chronic Conditions model.Results Twelve studies were included from Nigeria (n=7), Ghana (n=4), and Senegal (n=1). Key barriers to access, utilisation, and quality were identified as health system deficiencies, including lack of infrastructure, workforce shortages, supply gaps, fragmented care coordination, absence of standardised guidelines, high costs of care, and limited governance for chronic disease management. Broader determinants of health, such as poverty, gender, cultural beliefs, reliance on traditional medicine, and health policy gaps, were found to influence access to and utilisation of care significantly. Individual-level barriers like psychological distress and delays in care-seeking were also significant. However, family/social support systems emerged as potential facilitators of accessing and utilising PHC services.Conclusions Our review indicates a complex interplay between health system deficiencies, deeply rooted cultural beliefs, and lived experiences shaping diabetes care in West Africa. The region’s unique challenges demand a paradigm shift from conventional chronic care models to context-specific, adaptive models. Crucially, the gendered aspects of care and the integration of traditional healing practices emerge as pivotal yet often overlooked factors in diabetes management. Furthermore, addressing the bidirectional relationship between mental health and diabetes offers a promising avenue for improving outcomes. Future strategies must transcend the biomedical model, embracing a sociocultural approach that leverages community assets and addresses structural inequities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the NIHR Global Health Research Centre for Non-Communicable Disease Control in West Africa using UK aid from the UK Government to support global health research. Funding was received from the National Institute for Health Research (NIHR) Global Health Research Centre (grant number NHIR203246) on Strengthening of Capacity for NCD Control in West Africa (Stop-NCD) (https://nihr.ac.uk/). Funding was awarded to IA and TM. The focus of this research is to strengthen the capacity for NCD control in West Africa. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon reasonable request